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Purpose: The purpose of this study was to test the hypothesis that venous outflow of a Brescia fistula that is patent but
unusable for one of a variety of reasons can provide adequate drainage to sustain a prosthetic arteriovenous graft based
on the brachial artery, thus sparing more proximal veins for future access procedures.
Methods: The operation consists of placement of a prosthetic graft between the brachial artery in the antecubital space and
the cephalic vein at the wrist.
Results: Between December 1998 and November 1999, 14 patients (eight male and six female; age range, 34 to 73 years;
mean age, 51 years) underwent the operation. The original fistulae had been in place for 5 to 27 months (mean, 13
months). Thirteen grafts were patent at 30 days; the one early failure (24 days) was caused by infection. As of May 31,
2001, four grafts were being used (18 1⁄2, 20, 23, and 28 months after placement) and four had been withdrawn in a
functional state because of death (n  3) or transplantation (n  1). Primary functional patency rate with life-table
analysis was 71%, 57%, 41%, and 41% at 3, 6, 9, and 12 months; secondary functional patency rate was 86%, 78%, 52%,
and 52% at these same intervals. Three grafts had primary functional patencies greater than 18 months.
Conclusion: Patent but unusable Brescia fistulae can provide adequate outflow to sustain arteriovenous grafts, thus
sparing more proximal veins for future access procedures. The operation can extend by months or years the time during
which satisfactory vascular access can be maintained in these patients, potentially increasing survival in some cases. We
hope that the availability of this salvage option will encourage vascular surgeons to attempt arteriovenous fistulae at the
wrist even in patients with suboptimal venous anatomy. (J Vasc Surg 2002;36:346-50.)
Maintenance of long-term vascular access for patients
undergoing hemodialysis is an ongoing challenge. An arte-
riovenous fistula with native vessels at the wrist as described
by Brescia and colleagues1 is currently the most desirable
form of access, but successful fistulae cannot be established
in all patients.2-4 Unless the operation is restricted to those
with the most favorable venous anatomy, many procedures
will fail. Only if surgeons pursue an aggressive policy of
autologous arteriovenous fistula formation, with veins of
marginal quality (size, shape, visibility, and continuity), and
include all patients, regardless of age, gender, or disease,
will they maximize the number of successful native fistulae.
As a corollary, they will have a higher failure rate than if they
restricted the operation to thin young patients with favor-
able anatomy. However, two types of failure exist. Among
fistulae that do not develop, some thrombose acutely and
fail completely. Others remain patent but, even after many
months, continue to be too small, too short, too deep, or
too fragile or otherwise inadequate to permit reliable dual
cannulation. In the past, such fistulae were simply aban-
doned. More recently, we developed an operation to use
them in a novel way. We reasoned that if venous outflow is
adequate to keep a native fistula patent it should also be
adequate to provide satisfactory outflow for an arterio-
venous graft originating from the brachial artery. If success-
ful, this procedure would preserve antecubital and more
proximal veins for future access procedures.
METHODS
The operation consists of placement of a prosthetic
graft (polytetrafluoroethylene or bovine arterial hetero-
graft) from the brachial artery in the antecubital space to
the most distal dilated segment of the cephalic vein at the
wrist. The end of the graft, appropriately beveled, is anas-
tomosed to the side of the vein. The vein must be ligated
distally to isolate it from the original anastomosis to the
radial artery to prevent competing arterial inflow. The
brachial artery is exposed through a longitudinal incision to
avoid damage to the antecubital veins. The graft is placed in
a gentle arc, passing first to the ulnar side of the forearm,
then returning radially to the site of the original radioce-
phalic anastomosis, to facilitate conversion to a loop con-
figuration when the venous segment eventually fails. An
explanation that, unlike a traditional straight forearm graft,
flow is from the elbow toward the wrist, not vice versa, is
important for the dialysis personnel who will cannulate the
access. Thus, the arterial needle must be placed near the
elbow or high recirculation will occur.
Between December 1998 and November 1999, we
performed this procedure on 14 patients (eight male and six
female), ranging in age from 34 to 73 years (mean age, 51
years). The cause of end-stage renal disease was diabetic
nephropathy in seven patients, hypertension in five pa-
tients, polycystic kidney disease in one patient, and un-
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known in one patient. The fistulae had been in place from 5
to 27 months (mean, 13 months). Eleven had never been
used. The other three had functioned for 8, 12, and 25
months before becoming unusable, two because of inade-
quate arterial inflow (severely diseased radial arteries) and
one because of occlusion of the dominant vein in the mid
forearm at the site of venipuncture for an attempted angio-
plasty. Of the 11 fistulae that had never been used, six had
dilated segments too short to permit adequate separation of
arterial and venous needles, which was obvious on physical
examination, and dual cannulation was never attempted. In
every case, absence of a dominant cephalic vein from the
wrist to the antecubital space was seen. The vein may have
been congenitally absent or may have been destroyed with
prior venipunctures. In two other patients, the dominant
vein was patent and dilated throughout the forearm, as
shown with fistulogram, but could not be seen or ade-
quately located with palpation to permit needle placement.
Both patients were obese, and the veins lay deep in the
subcutaneous fat. Two additional patients had extensively
dilated thin-walled collateral vessels, which were too fragile
and too tortuous for use, in spite of multiple attempts with
a variety of needle placement strategies. In the final patient,
a large patent visible cephalic vein was seen throughout the
forearm, but it lacked adequate arterial inflow because of
intrinsic arterial disease as shown with arteriography (the
radial artery was diffusely narrowed, and the anastomosis
was widely patent). Eleven patients received modified bo-
vine arterial heterografts, and three received polytetrafluo-
roethylene grafts. Surgeon preference determined the
choice of graft material.
RESULTS
Overall results are summarized in the Figure. Out-
comes were analyzed as of May 31, 2001, permitting a
minimum follow-up period of 18 1⁄2 months. At the end of
the study, eight of 14 grafts were being used or had been
withdrawn in a functional state and six had failed. Of the
eight successful grafts, four were being used at 18 1⁄2, 20,
23, and 28 months after creation and four had been sup-
porting dialysis until withdrawn patent at the time of death
(3, 4, and 26 months) or transplantation (10 1⁄2 months).
The failures occurred at 24 days and 2 1⁄2, 5, 7, 8, and 9
months.
We considered grafts to be primarily patent if they
provided adequate flow for dialysis and did not need reop-
eration for any reason. We included one patient (patient 1)
who, at 3 1⁄2 months, had undergone a single prophylactic
angioplasty for stenosis without thrombosis. Nine of 12
at-risk grafts were primarily patent at 5 months, and seven
at 7 months. Life-table analysis results are shown in Table I
(online only). Primary patency rates were 71%, 57%, 41%,
and 41% at 3, 6, 9, and 12 months, respectively. Although
these percentages accurately describe our actual experience,
they do not reach statistical significance because of the
small number of patients.
Overall results. Primary patency rate includes one case of assisted primary patency: at 3 1⁄2 months, patient 1 underwent
prophylactic angioplasty for stenosis without thrombosis. Secondary patency rate includes one case of assisted
secondary patency: at 9 and 14 months, patient 8 underwent prophylactic angioplasties for stenosis without throm-
bosis. P, Patent on May 31, 2001; PD, patent at death; PT, patent at transplant; A, angioplasty for stenosis without
thrombosis; d, declot only for thrombosis after hypotension (no anatomic problem); DR, declot/revise stricture; X,
failed.
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We noted that three patients lost primary patency (at 34
days, 2 1⁄2 months, and 13 months) after episodes of hypo-
tension. On exploration, no anatomic problems were iden-
tified. The anastomoses were exposed. The grafts were
opened just proximal to the suture lines. Fogarty embolec-
tomy catheters were used to extract thrombus. The bal-
loons passed easily through the anastomoses. Patch angio-
plasty was not deemed necessary. The grafts were simply
declotted. One failed after an additional 3 months and was
successfully converted to a loop. The other two functioned
without further intervention until the patients died 2 and
13 months later. This suggests that the initial thromboses
were caused by physiologic failure (hypotension) rather
than anatomic deficiencies of the grafts, the anastomoses,
or the outflow veins.
Secondary patency includes those grafts that continued
to be usable after a single surgical intervention. Life-table
analysis results revealed a secondary patency rate of 86% at
3 months, 78% at 6 months, and 52% at 9 months and
thereafter (Table II, online only). Because of the small
number of patients, these percentages do not reach statis-
tical significance. In summary, among the 12 patients who
survived more than 6 months after the initial operation,
nine had grafts that functioned at least 7 months, seven
primarily and two after a single surgical intervention.
One early failure (less than 30 days) did occur. The
patient had a wound infection develop, and the graft clot-
ted on the 24th postoperative day. Reoperation was not
attempted. Late failures occurred at 2 1⁄2, 5, 7, 8, and 9
months. These grafts clotted and could not be successfully
reopened. Four of the five underwent conversion to loop
configurations with an antecubital vein for outflow; the
fifth, treated elsewhere, had a new graft placed in the upper
arm, apparently without exploration of the antecubital
space for an appropriate outflow vein. Three of the four
loops were still functioning on May 31, 2001 (11, 13 1⁄2,
and 19 months after creation). The fifth failed acutely, and
the patient was eventually switched to peritoneal dialysis.
Because the arterial limb was already incorporated into the
surrounding tissue, the new loops could be cannulated
immediately, obviating the need for central venous cathe-
ters.
DISCUSSION
General agreement exists that an autologous arterio-
venous fistula at the wrist as described by Brescia and
colleagues1 is currently the vascular access of choice for
chronic hemodialysis.2-4 This is the conclusion reached by
the Dialysis Outcome Quality Initiative (DOQI) after a
panel of experts reviewed the world literature on this topic.
The finding was classified as “evidence based,” the panel’s
most authoritative designation.3 Many authors attest to the
durability, ease of use, and low incidence rate of complica-
tions with this access once a mature fistula has been estab-
lished.2,5-7 Unfortunately, successful fistulae cannot be cre-
ated in all patients. Early failures are common, with
published 1-year patency rates as low as 29%.6 Some au-
thors, however, report 88% success at 1 year.8 Because the
operation is more or less standardized and technically
straightforward, these differences almost certainly repre-
sent differences in patient selection. If the operation is
performed only in patients with ideal anatomy, those with
large dominant cephalic veins that are visibly patent
throughout the forearm, excellent results should be rou-
tinely obtained. If, however, the operation is attempted in
patients with less favorable venous anatomy (small veins,
veins damaged with prior venipunctures or not visible
because of obesity), one would anticipate less favorable
results.
Preoperative assessment of forearm veins has been re-
ported with a variety of techniques: ultrasonography, con-
ventional venography, and magnetic resonance venogra-
phy. These studies can help to identify patients with
optimal and marginal venous anatomy.9-12 To date, how-
ever, no absolutely reliable guidelines are predictive of
which patients with marginal veins will and will not have
usable fistulae develop. We have had patients with unfavor-
able venous anatomy have usable fistulae develop. Further-
more, as our experience shows, an autologous fistula may
be useful even if it is not usable. Clearly, a fistula will never
develop if it is not created in the first place. Thus, surgeons
who concentrate on their rates of success will probably not
attempt autologous wrist fistulae in patients with unfavor-
able anatomy, thus denying these patients any possible
chance for development of this most optimal of access
systems. To minimize this possibility, the DOQI work
group recommended that primary failure rate of native
arteriovenous fistulae not be used as an indicator of quality
because “to do otherwise might discourage native fistulae
creation in patients with more complex vascular anatomy
(ie, in patients who are at a higher risk for failure).”13
Clearly, only if surgeons pursue an aggressive policy of
autologous arteriovenous wrist fistula creation, with veins
of marginal length and caliber and with elderly, diabetic,
and obese patients, will they maximize the number of such
fistulae. For several years, we have followed a policy of
attempting native wrist fistulae in all patients in whom
creation of an arteriovenous anastomosis was technically
possible—without regard to the size, continuity, or visibil-
ity of a dominant vein and without consideration of patient
age, gender, or disease. Thus, in 1998, we created wrist
fistulae in 42 of 45 patients (92%) who were referred for
their initial access procedures. Our success rate was approx-
imately 50% at 6 months, such that 45% of our new patients
were undergoing dialysis with native fistulae rather than
grafts. This is about twice the national average and satisfies
DOQI guidelines for the ratio of grafts to fistulae in the
hemodialysis population.14 In addition to the completely
successful fistulae, we were, however, faced with a number
of patients whose fistulae were patent but unusable because
the vein was not adequately developed to permit reliable
dual cannulation without recirculation. In the past, we
either abandoned such fistulae or used them as the arterial
anastomosis for a straight graft from the wrist to the ante-
cubital space. This time, as discussed previously, we chose
to use the dilated matured vein at the wrist to provide
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outflow for a prosthetic graft based on the distal brachial
artery. We reasoned that if this procedure were successful, it
would spare antecubital and more proximal veins for future
access procedures.
An additional theoretic advantage of this operation is
that, with increasing flow through veins in the distal fore-
arm, enlargement of other veins might occur in the same
extremity. Polo and colleagues15 have invoked this princi-
ple in advocating the use of short brachiocephalic jump
grafts to dilate upper arm veins. They found that the
increased pressure and flow caused the cephalic, basilic, and
antecubital veins to enlarge and mature, making them
suitable for repeated venipunctures. By analogy, this same
principle should apply to other arm veins that have been
arterialized at the wrist. We have no data to either support
or refute this hypothesis. Even if the concept is correct, we
would consider it of only secondary importance. The pri-
mary benefits of our operation remain the preservation of
proximal veins and a new rationale for use of more liberal
criteria in selection of patients for creation of autologous
fistulae at the wrist.
Two of our obese patients had dominant cephalic veins
that with fistulogram were patent and dilated throughout
the forearm but could not be reliably cannulated because
they were located too deep in the subcutaneous fat to be
visualized or adequately localized with palpation. These
patients might have been treated with relocation of the
veins to a more superficial position, analogous to basilic
vein transposition in the upper arm. Silva and colleagues16
have reported the use of vein transposition to permit cre-
ation of autologous forearm fistulae in 89 patients. They
achieved primary patency rates of 84% at 1 year and 69% at
2 years, with a mean follow-up period of 14.3 months.
Veins were transposed because they were “remote from the
arterial source of inflow.” In none of their patients was the
vein relocated because of obesity. Although equally good
results might possibly be achieved in obese patients, that
remains to be proven. Nevertheless, this option should be
considered in patients whose veins appear to be adequate
on fistulogram but who cannot reliably undergo cannula-
tion because of obesity.
Several of our patients underwent one or more fistulo-
grams that revealed no anatomic abnormalities, that is, no
anastomotic or intragraft stenoses. The indications for
these studies were usually high recirculation or high venous
pressure. Given the normal angiographic findings, we be-
lieve that some of these apparent functional abnormalities
were caused by improper needle placement. As explained
previously, unlike conventional straight forearm grafts,
flow in these patients is centrifugal, from elbow to wrist. If
these patients underwent cannulation in the usual fashion,
with the venous needle near the elbow and the arterial
needle near the wrist, high recirculation would be inevita-
ble and high venous pressure would be likely. If this is done
repeatedly, it will lead to chronic underdialysis. Therefore,
it is essential that the patients and everyone involved in their
care (surgeons, nephrologists, nurses, technicians, and fam-
ily members) understand the direction of flow in these
grafts and the proper method of cannulation.
How can we gauge the success of this concept? Like all
other access systems, these grafts will eventually fail. One
would not expect them to have the durability of a native
fistula. With a lack of a single dominant outflow vein, they
are likely to be less durable and more difficult to declot and
revise than standard graft configurations. Important to
note, however, is that whatever their duration of function,
these grafts use veins that would otherwise be ignored.
Their period of usefulness is therefore additive to the total
time that satisfactory vascular access can be maintained in
these patients. Currently, because of the high mortality rate
among dialysis patients, it is likely that few patients die
because of exhaustion of all access sites. If, as is likely, the
mortality rate is eventually lowered, lack of vascular access
may increasingly determine the length of survival of pa-
tients on chronic hemodialysis. Each and every vascular
procedure must therefore be viewed, not in isolation, but as
a piece of a mosaic, part of an overall plan to provide
lifetime access for that patient. Thus, if this operation adds
even a few months of functional access, it may make a
meaningful contribution to the overall survival of some
patients on chronic hemodialysis.
Our results satisfy DOQI guidelines for primary access
failure for arteriovenous grafts. Guideline 33 specifies that
forearm straight grafts should have a 30-day primary failure
rate of less than 15%.17 We had only one early failure
among 14 patients (7%), which was caused by a wound
infection rather than a failure of the concept of the opera-
tion.
Although our series is small and follow-up is limited, it
is unlikely that this operation can satisfy the DOQI guide-
line for the accumulative patency of dialysis arteriovenous
grafts (guideline 36), which calls for patency rates of 70%,
60%, and 50% at 1, 2, and 3 years, respectively.18 This is
because the veins we use are smaller and more tortuous and
generally lack a dominant outflow channel. One would
therefore predict earlier development of venous stenosis
and greater difficulty in achievement of complete declot-
ting. Nevertheless, as discussed previously, this operation
uses veins that would otherwise have been abandoned and
preserves more proximal veins for future use. Thus, even if
these grafts prove less durable than conventionally placed
ones, whatever patency they do achieve will only add to the
length of time that adequate access is available to these
patients. (Addendum: with regard to durability, an update
of our experience as of November 31, 2001, revealed that
all five grafts that were in use 12 months after creation were
still in use 12 months later.)
We conclude that patent but unusable Brescia fistulae
can provide adequate outflow to sustain usable arterio-
venous grafts, thus preserving more proximal veins for
future access procedures. Early experience proves this op-
eration capable of at least intermediate-term success and
suggests that it may provide a meaningful addition to the
survival of some patients on chronic hemodialysis. More-
over, the availability of this salvage option should encour-
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age vascular surgeons to be more aggressive in creating
autologous arteriovenous fistulae at the wrist, attempting
the operation even with patients with suboptimal venous
anatomy. Although not all of these fistulae will develop into
useful access systems, some will, thus decreasing or delaying
the need for prosthetic grafts. As our experience shows,
even those fistulae that are not completely successful may
still play an important role in the long-term management of
patients on chronic hemodialysis.
We thank Ruixue Liu, Statistics Department Consult-
ing Service, Stanford University, and Tamara Bushnik,
PhD, Rehabilitation Research Center, Santa Clara Valley
Medical Center, for their help with the survival analysis in
this report.
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